NEONC TECHNOLOGIES HOLDINGS, INC. Deferred Costs, Current
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) had Deferred Costs, Current of $137.79 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Current › Deferred Costs, Current
us-gaap:DeferredCostsCurrent · last filed 2026-08-10
- 2026-06-30: Deferred Costs, Current $137.79K.
- 2026-03-31: Deferred Costs, Current $50.86K.
- 2025-12-31: Deferred Costs, Current $75.08K.
- 2025-09-30: Deferred Costs, Current $99.30K.
| Period end | Deferred Costs, Current |
|---|---|
| 2026-06-30 | $137.79K 10-Q · filed 2026-08-10 |
| 2026-03-31 | $50.86K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $75.08K 10-Q · filed 2026-08-10 |
| 2025-09-30 | $99.30K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $96.88K 10-Q · filed 2025-08-18 |
| 2025-03-31 | $96.88K 10-Q · filed 2025-05-09 |
| 2024-12-31 | $1.07M 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |